×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CGON – cg oncology, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CGON
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/31
08:16 am
cgon
CG Oncology, Inc. (NASDAQ: CGON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
Neutral
Report
CG Oncology, Inc. (NASDAQ: CGON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
3/31
08:00 am
cgon
CG Oncology to Participate in the 120th American Urological Association Annual Meeting with a Series of Key Presentations and Updates
Neutral
Report
CG Oncology to Participate in the 120th American Urological Association Annual Meeting with a Series of Key Presentations and Updates
3/28
07:00 am
cgon
CG Oncology Reports 2024 Year End Financial Results and Provides Business Updates
Low
Report
CG Oncology Reports 2024 Year End Financial Results and Provides Business Updates
3/26
08:13 pm
cgon
Is CG Oncology (CGON) Among the Best IPO Stocks to Buy in 2025? [Yahoo! Finance]
Medium
Report
Is CG Oncology (CGON) Among the Best IPO Stocks to Buy in 2025? [Yahoo! Finance]
3/25
08:18 am
cgon
CG Oncology, Inc. (NASDAQ: CGON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
Low
Report
CG Oncology, Inc. (NASDAQ: CGON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
3/24
08:08 am
cgon
Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy [Yahoo! Finance]
Medium
Report
Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy [Yahoo! Finance]
3/24
08:00 am
cgon
Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy
Medium
Report
Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy
3/12
08:00 am
cgon
CG Oncology to Participate in the 40th Annual European Association of Urology Congress with a Series of Key Presentations and Updates
Low
Report
CG Oncology to Participate in the 40th Annual European Association of Urology Congress with a Series of Key Presentations and Updates
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/28
09:00 am
cgon
Form 10-K CG Oncology, Inc. For: Dec 31
Medium
Report
Form 10-K CG Oncology, Inc. For: Dec 31
3/28
07:15 am
cgon
Form 8-K CG Oncology, Inc. For: Mar 28
Low
Report
Form 8-K CG Oncology, Inc. For: Mar 28
3/24
08:30 am
cgon
Form 8-K CG Oncology, Inc. For: Mar 24
Medium
Report
Form 8-K CG Oncology, Inc. For: Mar 24
3/18
04:30 pm
cgon
Form 4 CG Oncology, Inc. For: Mar 17 Filed by: POST LEONARD E
Low
Report
Form 4 CG Oncology, Inc. For: Mar 17 Filed by: POST LEONARD E
3/17
04:38 pm
cgon
Form 144 CG Oncology, Inc. Filed by: POST LEONARD E
Low
Report
Form 144 CG Oncology, Inc. Filed by: POST LEONARD E
2/19
04:15 pm
cgon
Form 4 CG Oncology, Inc. For: Feb 18 Filed by: POST LEONARD E
Low
Report
Form 4 CG Oncology, Inc. For: Feb 18 Filed by: POST LEONARD E
2/14
05:40 pm
cgon
Form SCHEDULE 13G/A CG Oncology, Inc. Filed by: Decheng Capital Global Life Sciences Fund IV, L.P.
Medium
Report
Form SCHEDULE 13G/A CG Oncology, Inc. Filed by: Decheng Capital Global Life Sciences Fund IV, L.P.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: